Examination of the liver fibrosis improvement effect with the SGLT2 inhibitor for diabetes complicated by non-alcoholic steatohepatitis.
Not Applicable
- Conditions
- Type 2 diabetes complicated by non-alcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000027362
- Lead Sponsor
- Fukuoka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindication for SGLT2 inhibitor. Ineligible patients by judgement of family doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method